09/30/2015
The United Kingdom Medicines and Healthcare Products Regulatory Agency (MHPRA) made the decision on September 23, 2015, to suspend silicone implants manufactured by Silimed for concerns over potential particulate contamination.
Silimed is working with European agencies to provide technical documentation to resolve MHPRAs concerns. Additionally, Silimed has voluntarily suspended the sale of its products in the European market until health authorities receive Silimeds official technical report. Silimed has also reinforced through company statements that this issue is exclusively connected with the guidelines of the sanitation policy of the European Community and it complies with the other regulations in effect in other markets.
+cosmetic+surgery
ASPS will continue to monitor this effort very closely and provide updates to members as new information is learned. At this time we do not have information that suggests that this issue poses a threat to patients in the US. The health of breast augmentation and reconstruction patients is a high priority for the ASPS as demonstrated by our efforts to develop the National Breast Implant Registry (NBIR) for ongoing device surveillance and the Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma (ALCL) Etiology and Epidemiology (PROFILE) to better understand breast implant associated-Anaplastic Large Cell Lymphoma (BIA-ALCL). The ASPS and The Plastic Surgery Foundation are committed to developing clinical data tools to ensure patient safety and quality care of plastic surgery patients.
Silimed is a Brazilian company that has been manufacturing silicone implants for 37 years with product approvals in 75 countries. In 2007, Sientra acquired the rights to sell Silimed breast implants in the United States. In 2012, Sientra received FDA approval of its Silimed-brand portfolio of round and shaped silicone breast implants.
In a statement Sientra noted - The MHRA announcement has no applicability to Sientras products as it is applicable only to the distribution of Silimeds CE-marked implants in Europe. Hani Zeini, Founder and Chief Executive Officer Sientra, Inc., said. Our products are FDA-regulated and PMA-approved. Sientras breast implants and our other products continue to be marketed and available in the United States and there has been no change to the regulatory status of Sientras FDA-approved breast implants.
About Plastic and Reconstructive Surgery
For more than 60 years, Plastic and Reconstructive Surgery (PRS) has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, PRS brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair, and cosmetic surgery, as well as news on medico-legal issues.
About Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Healths customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. Major brands include Health Language, Lexicomp, Lippincott Williams & Wilkins, Medicom, Medknow, Ovid, Pharmacy OneSource, ProVation Medical and UpToDate.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2012 annual revenues of 3.6 billion ($4.6 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific and Latin America. Follow our official Twitter handle: @WKHealth.
About ASPS
The American Society of Plastic Surgeons (ASPS) is the world's largest organization of board-certified plastic surgeons. Representing more than 7,000 Member Surgeons, the Society is recognized as a leading authority and information source on aesthetic and reconstructive plastic surgery. ASPS comprises more than 94 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the Society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada. ASPS advances quality care to plastic surgery patients by encouraging high standards of training, ethics, physician practice and research in plastic surgery.
http://www.plasticsurgery.org/news/2015/silimed-ce-certificate-for-silicone-implants-in-the-european-market-suspended-by-mhpra.html
